Provided by Tiger Fintech (Singapore) Pte. Ltd.

ENDRA Life Sciences Inc

3.67
+0.32009.55%
Post-market: 3.57-0.1000-2.72%19:59 EDT
Volume:2.11M
Turnover:9.63M
Market Cap:2.06M
PE:-0.06
High:5.58
Open:3.35
Low:3.27
Close:3.35
Loading ...

Top broker says Mesoblast shares can rocket 100%

MotleyFool
·
08 Apr

ENDRA Life Sciences FY 2024 GAAP EPS $(56.94) Misses $(47.46) Estimate

Benzinga
·
31 Mar

ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging Glp-1 Therapies

THOMSON REUTERS
·
31 Mar

ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies

Business Wire
·
31 Mar

ENDRA Life Sciences Inc - Q4 Net Loss 2024 $4.2 Mln

THOMSON REUTERS
·
31 Mar

ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update

THOMSON REUTERS
·
31 Mar

Press Release: ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update

Dow Jones
·
31 Mar

Mesoblast announces it entered into NDRA with CMS DHHS for Ryoncil

TIPRANKS
·
31 Mar

First Three Children to Commence Treatment With Ryoncil®

GlobeNewswire
·
31 Mar

ENDRA Life Sciences Inc expected to post a loss of $4.10 a share - Earnings Preview

Reuters
·
24 Mar

What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock

Zacks
·
29 Jan

ENDRA Life Sciences Inc trading resumes

TIPRANKS
·
30 Nov 2024

ENDRA Life Sciences Inc trading halted, volatility trading pause

TIPRANKS
·
30 Nov 2024

BRIEF-Endra Life Sciences Regains Compliance With Nasdaq Minimum Bid Price Requirement

Reuters
·
22 Nov 2024

Endra Life Sciences regains compliance with Nasdaq

TIPRANKS
·
22 Nov 2024

ENDRA Life Sciences Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
22 Nov 2024

ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Business Wire
·
22 Nov 2024

ENDRA Life Sciences Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
15 Nov 2024

ENDRA Life Sciences Q3 EPS $(9.54)

Benzinga
·
15 Nov 2024

ENDRA Life Sciences Inc: Qtrly Loss per Share $9.54

THOMSON REUTERS
·
15 Nov 2024